Sodium Hyaluronate 0.18%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sodium Hyaluronate 0.18%, covering 2011-01-27 to 2011-01-27. Get the full timeline:
Most recent: Clinical Trial Update: Hydroxypropylmethylcellulose 0.3% and Sodium Hyaluronate 0.18% for Ocular Surface Disease in Glaucoma [NA]